drug | Keywords | EQUATOR Network

skip to main content

Enhancing the QUAlity and Transparency Of health Research

Website translation help

Navigate this website

Home > Library > Reporting guideline

Blog Archives

12/06/2024 The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement 12/06/2024 The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE) 27/10/2022 Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines 01/06/2022 Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS 10/03/2022 Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations 23/09/2020 STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline 28/11/2019 Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose 26/07/2017 Guidance to develop individual dose recommendations for patients on chronic hemodialysis 11/10/2016 Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective 20/04/2016 Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency

Blog archives

Latest guest blogger

New resource for research teams to improve the reporting of implementation studies

In this blog post, Dr Louise Hull, an implementation research lead, discusses the development of a new resource to help improve the reporting of implementation studies.